Title of article
α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity
Author/Authors
Sarah Wright، نويسنده , , Nikolay L. Malinin، نويسنده , , Kyle A. Powell، نويسنده , , Ted Yednock، نويسنده , , Russell E. Rydel، نويسنده , , Irene Griswold-Prenner، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
12
From page
226
To page
237
Abstract
Pathological hallmarks of Alzheimerʹs disease are the presence of extracellular amyloid plaques, intracellular neurofibrillary tangles, and neurodegeneration. The principal component of amyloid plaques is the amyloid-β peptide (Aβ). Accumulating evidence indicates that Aβ may play a causal role in Alzheimerʹs disease. In this report, we demonstrate that Aβ deposition and neurotoxicity in human cortical primary neurons are mediated through α2β1 and αVβ1 integrins using specific integrin-blocking antibodies. An aberrant integrin signaling pathway causing the neurotoxicity is mediated through Pyk2. The role of α2β1 and αVβ1 integrins can be extended to another amyloidosis using an amylin in vitro neurotoxicity model. These results indicate that the α2β1 and αVβ1 integrin signaling pathway may be critical components of neurodegeneration in Alzheimerʹs disease and that integrins may recognize and be activated by a shared structural motif of polymerizing amyloidogenic proteins.
Keywords
2 1 and V 1 integrin , Amyloid- , Pyk2 , Neurodegeneration , Alzheimer’s disease
Journal title
Neurobiology of Aging
Serial Year
2007
Journal title
Neurobiology of Aging
Record number
820932
Link To Document